Product nameAnti-Glucocorticoid Receptor beta antibody
See all Glucocorticoid Receptor beta primary antibodies
DescriptionRabbit polyclonal to Glucocorticoid Receptor beta
Tested applicationsSuitable for: ICC/IF, IHC-P, Flow Cyt, GSA, ICC, IP, WBmore details
Species reactivityReacts with: Sheep, Human, Pig
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.05% Sodium azide
Constituent: 99% PBS
Concentration information loading...
Immunizing Peptide (Blocking)
Our Abpromise guarantee covers the use of ab3581 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||Use a concentration of 5 µg/ml.
Fixation: 4% paraformaldehyde for 15 minutes at room temperature. Permeabilisation: PBS containing 0.01% saponin for 15 mins Blocking: 1% BSA in PBS Primary: overnight at 4ºC
|EMSA||Use at an assay dependent concentration.|
|IHC-P||Use at an assay dependent concentration. PubMed: 20438742Sample Preparation: endogenous peroxidase blocked with 0.3% hydrogen peroxide. Antigen retrieval: Heat induced antigen retrieval performed in 0.01M Tris-EDTA pH 9.0. Primary antibody: overnight at 4°C|
|Flow Cyt||Use at an assay dependent concentration.
ab171870 - Rabbit polyclonal IgG, is suitable for use as an isotype control with this antibody.
|GSA||Use at an assay dependent concentration.|
|IP||Use at an assay dependent concentration. Sample preparation: RIPA buffer containing protease inhibitors was added to cell lysate. Primary antibody: 1:10 dilution for 2 h on ice Prewashed magnetic beads added to lysate mixture and incubated overnight at +4ºC. After washing, sample reducing buffer was added and boiled (5 min, 95ºC)|
|WB||1/500. Detects a band of approximately 90 kDa (predicted molecular weight: 83 kDa).Can be blocked with Human Glucocorticoid Receptor beta peptide (ab39765). Sample preparation: Lysates boiled in reducing buffer for 5 min. 20µg of protein loaded Blocking agent: 5% non-fat milk in Tris buffered saline (TBS) Primary antibody: overnight at 4°C|
FunctionReceptor for glucocorticoids (GC). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE) and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth. Involved in chromatin remodeling. Plays a significant role in transactivation. Involved in nuclear translocation.
Tissue specificityWidely expressed. In the heart, detected in left and right atria, left and right ventricles, aorta, apex, intraventricular septum, and atrioventricular node as well as whole adult and fetal heart.
Involvement in diseaseDefects in NR3C1 are a cause of glucocorticoid resistance (GCRES) [MIM:138040]; also known as cortisol resistance. It is a hypertensive, hyperandrogenic disorder characterized by increased serum cortisol concentrations. Inheritance is autosomal dominant.
Sequence similaritiesBelongs to the nuclear hormone receptor family. NR3 subfamily.
Contains 1 nuclear receptor DNA-binding domain.
DomainComposed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.
modificationsIncreased proteasome-mediated degradation in response to glucocorticoids.
Phosphorylated in the absence of hormone; becomes hyperphosphorylated in the presence of glucocorticoid. The Ser-203-phosphorylated form is mainly cytoplasmic, and the Ser-211-phosphorylated form is nuclear. Transcriptional activity correlates with the amount of phosphorylation at Ser-211.
Sumoylated; this reduces transcription transactivation.
Ubiquitinated; restricts glucocorticoid-mediated transcriptional signaling.
Cellular localizationCytoplasm. Nucleus. Cytoplasmic in the absence of ligand, nuclear after ligand-binding and Nucleus. Localized largely in the nucleus.
- Information by UniProt
- GCCR antibody
- GCR antibody
- GCR_HUMAN antibody
ICC/IF image of ab3581 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab3581, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
All lanes : Anti-Glucocorticoid Receptor beta antibody (ab3581) at 1/500 dilution
Lane 1 : COS-74 whole cell extract transfected with Glucocorticoid Receptor alpha
Lane 2 : COS-74 whole cell extract transfected with Glucocorticoid Receptor beta
Predicted band size: 83 kDa
This product has been referenced in:
- Zhang H et al. Mucin 1 downregulation impairs the anti-necroptotic effects of glucocorticoids in human bronchial epithelial cells. Life Sci 221:168-177 (2019). Read more (PubMed: 30738043) »
- Butler CA et al. Glucocorticoid receptor ß and histone deacetylase 1 and 2 expression in the airways of severe asthma. Thorax 67:392-8 (2012). ICC/IF ; Human . Read more (PubMed: 22156779) »